NAPOLI-3: A randomized, open-label Phase 3 study of liposomal irinotecan+5-fluorouracil/leucovorin plus oxaliplatin (NALIRIFOX) versus nab-paclitaxel plus gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)

T. Goetze,D. Melisi,T. Macarulla, A. R. Pazo Cid,R. S. Chandana,C. De La Fouchardiere, A. Dean, I. Kiss, Jin W. Lee,E. Van Cutsem,S. Paulson, T. Bekaii-Saab,S. Pant,R. Hubner, Z. Xiao, H. Chen,F. Benzaghou, E. O'Reilly,A. Z. Wainberg

JOURNAL OF CLINICAL ONCOLOGY(2023)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要